##ANALYSISTYPE=SOMATIC_SINGLESAMPLE
##PIPELINE=megSAP 0.2-296-g569671f
##SAMPLE=<ID=GS150344_01,Gender=female,ExternalSampleName=151172,IsTumor=yes,IsFFPE=yes,DiseaseGroup=Neoplasms,DiseaseStatus=Affected>
##DESCRIPTION=filter=Annotations for filtering and ranking variants.
##DESCRIPTION=quality=Quality parameters - variant quality (QUAL), depth (DP), allele frequency (AF), mean mapping quality of alternate allele (MQM), probability of strand bias for alternate bases as phred score (SAP), probability of allele ballance as phred score (ABP)
##DESCRIPTION=gene=Affected gene list (comma-separated).
##DESCRIPTION=variant_type=Variant type.
##DESCRIPTION=coding_and_splicing=Coding and splicing details (Gene, ENST number, type, impact, exon/intron number, HGVS.c, HGVS.p, Pfam domain).
##DESCRIPTION=coding_and_splicing_refseq=Coding and splicing details based on RefSeq (Gene, RefSeq id, type, impact, exon/intron number, HGVS.c, HGVS.p, Pfam domain).
##DESCRIPTION=regulatory=Regulatory consequence details.
##DESCRIPTION=OMIM=OMIM database annotation.
##DESCRIPTION=ClinVar=ClinVar database annotation.
##DESCRIPTION=HGMD=HGMD database annotation.
##DESCRIPTION=RepeatMasker=RepeatMasker annotation.
##DESCRIPTION=dbSNP=Identifier in dbSNP database.
##DESCRIPTION=1000g=Allele frequency in 1000 genomes project.
##DESCRIPTION=gnomAD=Allele frequency in gnomAD project.
##DESCRIPTION=gnomAD_hom_hemi=Homoyzgous counts and hemizygous counts of gnomAD project (genome data).
##DESCRIPTION=gnomAD_sub=Sub-population allele frequenciens (AFR,AMR,EAS,NFE,SAS) in gnomAD project.
##DESCRIPTION=phyloP=phyloP (100way vertebrate) annotation. Deleterious threshold > 1.6.
##DESCRIPTION=Sift=Sift effect prediction and score for each transcript: D=damaging, T=tolerated.
##DESCRIPTION=PolyPhen=PolyPhen (humVar) effect prediction and score for each transcript: D=probably damaging, P=possibly damaging, B=benign.
##DESCRIPTION=fathmm-MKL=fathmm-MKL score (for coding/non-coding regions). Deleterious threshold > 0.5.
##DESCRIPTION=CADD=CADD pathogenicity prediction scores (scaled phred-like). Deleterious threshold > 10-20.
##DESCRIPTION=REVEL=REVEL pathogenicity prediction score. Deleterious threshold > 0.5.
##DESCRIPTION=MaxEntScan=MaxEntScan splicing prediction (reference bases score/alternate bases score).
##DESCRIPTION=GeneSplicer=GeneSplicer splicing prediction (state/type/coordinates/confidence/score).
##DESCRIPTION=dbscSNV=dbscSNV splicing prediction (ADA/RF score).
##DESCRIPTION=COSMIC=COSMIC somatic variant database anntotation.
##DESCRIPTION=MMSplice_DeltaLogitPSI=mmsplice splice variant effect: max. delta_logit_psi score (logit scale of variant's effect on the exon inclusion, positive score shows higher exon inclusion, negative higher excusion rate - a score beyond 2, -2 can be considered strong)
##DESCRIPTION=MMSplice_pathogenicity=mmsplice splice variant effect: max. pathogenicity score (probability of the pathogenic effect of the variant)
##DESCRIPTION=tumor_af=Mutant allele frequency in tumor (Sample GS150344_01).
##DESCRIPTION=tumor_dp=Tumor Depth (Sample GS150344_01).
##DESCRIPTION=somatic_classification_comment=Somatic classification comment from the NGSD.
##DESCRIPTION=somatic_classification=Somatic classification from the NGSD.
#chr	start	end	ref	obs	tumor_af	tumor_dp	filter	quality	gene	variant_type	coding_and_splicing	coding_and_splicing_refseq	regulatory	OMIM	ClinVar	HGMD	RepeatMasker	dbSNP	1000g	gnomAD	gnomAD_hom_hemi	gnomAD_sub	phyloP	Sift	PolyPhen	fathmm-MKL	CADD	REVEL	MaxEntScan	GeneSplicer	dbscSNV	COSMIC	MMSplice_DeltaLogitPSI	MMSplice_pathogenicity	somatic_classification_comment	somatic_classification
chr13	32911888	32911888	A	G	0.9933	149		QUAL=4875	BRCA2	synonymous	BRCA2:ENST00000380152:synonymous_variant:LOW:exon11/27:c.3396A>G:p.Lys1132=:,BRCA2:ENST00000544455:synonymous_variant:LOW:exon11/28:c.3396A>G:p.Lys1132=:			600185 [BRCA2 (confirmed) Breast-ovarian cancer,familial,2,612555/Fanconi anemia,complementation group D1,605724/Prostate cancer,176807/Breast cancer,male,susceptibility to,114480/Wilms tumor,194070/Medulloblastoma,155255/Glioblastoma 3,613029/Pancreatic cancer 2,613347];				rs1801406	0.2668	0.2947		0.2277,0.2127,0.3820,0.3087,0.2994	0.2130			0.49,0.90	0.34					COSM4415776	0.0033	0.158	I am an deleterious variant class	activating
chr13	32913055	32913055	A	G	1.0000	169		QUAL=5583	BRCA2	synonymous	BRCA2:ENST00000380152:synonymous_variant:LOW:exon11/27:c.4563A>G:p.Leu1521=:PF00634 [BRCA2 repeat],BRCA2:ENST00000544455:synonymous_variant:LOW:exon11/28:c.4563A>G:p.Leu1521=:PF00634 [BRCA2 repeat]			600185 [BRCA2 (confirmed) Breast-ovarian cancer,familial,2,612555/Fanconi anemia,complementation group D1,605724/Prostate cancer,176807/Breast cancer,male,susceptibility to,114480/Wilms tumor,194070/Medulloblastoma,155255/Glioblastoma 3,613029/Pancreatic cancer 2,613347];				rs206075		0.9945		0.9252,0.9956,0.9999,0.9996,0.9999	0.0710			0.00,0.27	0.03						0.0008	0.1579		
chr13	32915005	32915005	G	C	1.0000	102		QUAL=3321	BRCA2	synonymous	BRCA2:ENST00000380152:synonymous_variant:LOW:exon11/27:c.6513G>C:p.Val2171=:,BRCA2:ENST00000544455:synonymous_variant:LOW:exon11/28:c.6513G>C:p.Val2171=:			600185 [BRCA2 (confirmed) Breast-ovarian cancer,familial,2,612555/Fanconi anemia,complementation group D1,605724/Prostate cancer,176807/Breast cancer,male,susceptibility to,114480/Wilms tumor,194070/Medulloblastoma,155255/Glioblastoma 3,613029/Pancreatic cancer 2,613347];				rs206076		0.9943		0.9251,0.9955,0.9999,0.9995,0.9999	-0.8750			0.02,0.13	0.45					COSM4147690	-0.001	0.1579		
chr13	32929387	32929387	T	C	1.0000	123		QUAL=4062	BRCA2	missense	BRCA2:ENST00000380152:missense_variant:MODERATE:exon14/27:c.7397T>C:p.Val2466Ala:,BRCA2:ENST00000544455:missense_variant:MODERATE:exon14/28:c.7397T>C:p.Val2466Ala:			600185 [BRCA2 (confirmed) Breast-ovarian cancer,familial,2,612555/Fanconi anemia,complementation group D1,605724/Prostate cancer,176807/Breast cancer,male,susceptibility to,114480/Wilms tumor,194070/Medulloblastoma,155255/Glioblastoma 3,613029/Pancreatic cancer 2,613347];				rs169547	0.9758	0.9950		0.9322,0.9958,0.9999,0.9997,0.9999	2.3520	T(0.11),T(0.11)	B(0.88),B(0.88)	0.00,0.10	0.86	0.09					0.1306	0.5302		
chr17	41226536	41226536	G	T	0.4902	102		QUAL=1291	BRCA1	stop_gained&splice_region,intron,splice_region&5'UTR	BRCA1:ENST00000309486:stop_gained&splice_region_variant:HIGH:exon13/22:c.3599C>A:p.Ser1200Ter:,BRCA1:ENST00000346315:intron_variant:MODIFIER:intron12/18:c.4357+7885C>A::,BRCA1:ENST00000351666:stop_gained&splice_region_variant:HIGH:exon10/19:c.938C>A:p.Ser313Ter:,BRCA1:ENST00000352993:stop_gained&splice_region_variant:HIGH:exon13/22:c.1061C>A:p.Ser354Ter:,BRCA1:ENST00000354071:intron_variant:MODIFIER:intron12/17:c.4357+7885C>A::,BRCA1:ENST00000357654:stop_gained&splice_region_variant:HIGH:exon14/23:c.4487C>A:p.Ser1496Ter:,BRCA1:ENST00000468300:stop_gained&splice_region_variant:HIGH:exon14/22:c.1175C>A:p.Ser392Ter:,BRCA1:ENST00000471181:stop_gained&splice_region_variant:HIGH:exon15/24:c.4550C>A:p.Ser1517Ter:,BRCA1:ENST00000491747:stop_gained&splice_region_variant:HIGH:exon14/23:c.1175C>A:p.Ser392Ter:,BRCA1:ENST00000493795:stop_gained&splice_region_variant:HIGH:exon13/22:c.4346C>A:p.Ser1449Ter:,BRCA1:ENST00000586385:intron_variant:MODIFIER:intron1/7:c.5-10568C>A::,BRCA1:ENST00000591534:splice_region_variant&5_prime_UTR_variant:LOW:exon2/11:c.-41C>A::,BRCA1:ENST00000591849:intron_variant:MODIFIER:intron1/4:c.-98-24329C>A::			113705 [BRCA1 (confirmed) Breast-ovarian cancer,familial,1,604370/Pancreatic cancer,susceptibility to,4,614320/Fanconi anemia,complementation group S,617883];				rs80356953					1.1860			0.58,0.53	5.76		12.00>11.67				-0.4777	0.7898	I am an unknown somatic variant classification	n/a
